Science News
about Medications
Find
Press Releases and Science Updates
by Topic
- Combination Treatment Most Effective in Adolescents with Depression
-
August 17, 2004
•
Press Release
A clinical trial of 439 adolescents with major depression has found a combination of medication and psychotherapy to be the most effective treatment.
- Research to Test Treatment of Cognitive Dysfunction in Schizophrenia
-
May 6, 2004
•
Press Release
The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).
- “Care Managers” Help Depressed Elderly Reduce Suicidal Thoughts
-
March 2, 2004
•
Press Release
An intervention that includes staffing doctors' offices with depression care managers helps depressed elderly patients reduce suicidal thoughts, a study funded by NIMH has found. Martha Bruce, Ph.D., Cornell University, Charles Reynolds, III, M.D., University of Pittsburgh, and colleagues report on the outcome of the intervention in three major Eastern U.S. metropolitan areas.
- Creation of New Neurons Critical to Antidepressant Action in Mice
-
August 7, 2003
•
Press Release
Blocking the formation of neurons in the hippocampus blocks the behavioral effects of antidepressants in mice, say researchers funded by the National Institutes of Health (NIH).
- Medication and Psychotherapy Treat Depression in Low-Income Minority Women
-
July 1, 2003
•
Press Release
Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH).
- Lithium Shows Promise Against Alzheimer’s in Mouse Model
-
May 21, 2003
•
Press Release
An enzyme crucial to formation of Alzheimer’s plaques and tangles may hold promise as a target for future medications, suggest studies in mice and cells.
- Brain Shrinkage in ADHD Not Caused by Medications
-
October 8, 2002
•
Press Release
A 10-year study by National Institute of Mental Health (NIMH) scientists has found that brains of children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) are 3-4 percent smaller than those of children who don't have the disorder—and that medication treatment is not the cause.
- Attention Deficit/Hyperactivity Disorders: Are Children Being Overmedicated?
-
September 26, 2002
•
Press Release
ADHD is the most extensively studied mental disorder of children, with several thousands of peer–reviewed papers in the scientific literature devoted to this topic. ADHD—which affects an estimated 3-5 percent or 2 million young school-age children and an unknown number of teenagers and adults—refers to a family of related chronic neurobiological disorders that interfere with an individual’s capacity to regulate activity level, inhibit behavior, and attend to tasks in developmentally appropriate ways.
- NIMH Study Finds Anti-Psychotic Medication Useful in Treating Serious Behavioral Problems among Children with Autism
-
July 31, 2002
•
Press Release
One of a newer class of anti-psychotic medications was successful and well tolerated for the treatment of serious behavioral disturbances associated with autistic disorder in children ages 5 to 17.
- Drug Targets Brain Circuits that Drive Appetite and Body Weight
-
July 25, 2002
•
Press Release
Research conducted in animals has revealed that an appetite suppressant drug, D-–fenfluramine (D–FEN), activates brain pathways that regulate food intake and body weight.
